NCT01555853 Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma Status TERMINATED Phase PHASE1
NCT01506973 A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01446016 Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) Status COMPLETED Phase PHASE2
NCT01207102 Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00970996 Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT00934895 Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca Status TERMINATED Phase PHASE1/PHASE2
NCT00821964 Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00736944 Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00723125 Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00691054 Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy Status COMPLETED Phase PHASE2
NCT00625573 Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) Status COMPLETED Phase PHASE2
NCT00583349 Intravesicular Abraxane for Treatment-Refractory Bladder Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00570674 Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck Status TERMINATED Phase PHASE1/PHASE2
NCT00521781 Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer Status TERMINATED Phase PHASE2
NCT00520000 Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00503906 Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00479674 Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00473720 Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers Status COMPLETED Phase PHASE1
NCT00466986 Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer Status COMPLETED Phase PHASE2